Lucid Diagnostics Inc. (LUCD): R&D Expense

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$5.68M

Year ended 2025-12-31

$5.39M

Trailing 12 months to 2026-06-30

-20.4%

3-year compound annual growth

2020-12-31 R&D Expense (USD) 2025-12-31

Period ended	R&D Expense	Change YoY	Source filing
2025-12-31	$5.68M	-5.2%	2026-03-25, From 2025-01-01
2024-12-31	$5.99M	-17.4%	2026-03-25, From 2024-01-01
2023-12-31	$7.25M	-35.6%	2025-03-24, From 2023-01-01
2022-12-31	$11.26M	n/c	2024-03-25, From 2022-01-01
2021-12-31	$9.30M	+70.8%	2023-03-14, From 2021-01-01
2020-12-31	$5.44M	n/a	2022-04-06, From 2020-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	R&D Expense	Change YoY
Lucid Diagnostics Inc. (LUCD)	2025-12-31	$5.68M	-5.2%
Picard Medical, Inc. (PMI)	2025-12-31	$3.05M	-9.8%
Cerenome, Inc. (CNSY)	2025-12-31	$8.38M	-20.8%
Tenon Medical, Inc. (TNON)	2025-12-31	$2.15M	-17.4%
IceCure Medical Ltd. (ICCM)	2025-12-31	$7.43M	+4.7%
INVO Fertility, Inc. (IVF)	2024-12-31	$4.9K	-97.1%
OSR Health, Inc. (OSRH)	2025-12-31	$318.4K	+97.6%
Beyond Air, Inc. (XAIR)	2026-03-31	$10.24M	-39.2%
QHSLab, Inc. (USAQ)	2025-12-31	$484.9K	+64.7%

Compare LUCD, PMI, CNSY, TNON side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗